ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 215 filers reported holding ICU MED INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,251,390 | -33.2% | 10,515 | -0.0% | 0.01% | -28.6% |
| Q2 2023 | $1,874,024 | +107912.9% | 10,517 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $1,735 | +4.8% | 10,517 | 0.0% | 0.01% | +7.7% |
| Q4 2022 | $1,656 | -99.9% | 10,517 | +0.0% | 0.01% | 0.0% |
| Q3 2022 | $1,583,000 | -14.8% | 10,515 | -6.9% | 0.01% | -18.8% |
| Q2 2022 | $1,858,000 | -20.5% | 11,300 | +7.6% | 0.02% | 0.0% |
| Q1 2022 | $2,338,000 | +4.4% | 10,500 | 0.0% | 0.02% | -5.9% |
| Q4 2021 | $2,240,000 | -9.9% | 10,500 | -1.4% | 0.02% | +13.3% |
| Q3 2021 | $2,485,000 | +13.4% | 10,650 | 0.0% | 0.02% | +7.1% |
| Q2 2021 | $2,192,000 | -5.1% | 10,650 | -5.3% | 0.01% | -6.7% |
| Q1 2021 | $2,311,000 | -4.2% | 11,250 | 0.0% | 0.02% | -6.2% |
| Q4 2020 | $2,413,000 | +14.1% | 11,250 | -2.8% | 0.02% | -5.9% |
| Q3 2020 | $2,114,000 | -0.2% | 11,569 | +0.7% | 0.02% | -10.5% |
| Q2 2020 | $2,118,000 | -14.7% | 11,493 | -6.6% | 0.02% | -32.1% |
| Q1 2020 | $2,482,000 | +13.4% | 12,300 | +5.1% | 0.03% | +47.4% |
| Q4 2019 | $2,189,000 | +18.8% | 11,700 | +1.3% | 0.02% | +18.8% |
| Q3 2019 | $1,843,000 | -30.3% | 11,550 | +10.0% | 0.02% | -36.0% |
| Q2 2019 | $2,645,000 | +5.3% | 10,500 | 0.0% | 0.02% | +4.2% |
| Q1 2019 | $2,513,000 | +4.2% | 10,500 | 0.0% | 0.02% | -11.1% |
| Q4 2018 | $2,411,000 | -18.8% | 10,500 | 0.0% | 0.03% | 0.0% |
| Q3 2018 | $2,969,000 | -4.0% | 10,500 | -0.3% | 0.03% | -15.6% |
| Q2 2018 | $3,092,000 | +15.9% | 10,530 | -0.4% | 0.03% | +14.3% |
| Q1 2018 | $2,668,000 | +16.3% | 10,570 | -0.5% | 0.03% | +16.7% |
| Q4 2017 | $2,294,000 | +16.7% | 10,620 | +0.4% | 0.02% | +9.1% |
| Q3 2017 | $1,966,000 | +7.7% | 10,580 | 0.0% | 0.02% | +4.8% |
| Q2 2017 | $1,825,000 | +12.7% | 10,580 | -0.3% | 0.02% | +10.5% |
| Q1 2017 | $1,620,000 | +2.7% | 10,610 | -0.8% | 0.02% | 0.0% |
| Q4 2016 | $1,577,000 | +16.6% | 10,700 | 0.0% | 0.02% | +5.6% |
| Q3 2016 | $1,352,000 | +12.1% | 10,700 | 0.0% | 0.02% | +12.5% |
| Q2 2016 | $1,206,000 | +8.3% | 10,700 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $1,114,000 | -7.7% | 10,700 | 0.0% | 0.02% | -5.9% |
| Q4 2015 | $1,207,000 | +3.0% | 10,700 | 0.0% | 0.02% | -5.6% |
| Q3 2015 | $1,172,000 | +14.5% | 10,700 | 0.0% | 0.02% | +20.0% |
| Q2 2015 | $1,024,000 | +2.7% | 10,700 | 0.0% | 0.02% | +7.1% |
| Q1 2015 | $997,000 | +15.9% | 10,700 | +1.9% | 0.01% | +16.7% |
| Q4 2014 | $860,000 | +143.6% | 10,500 | +90.9% | 0.01% | +140.0% |
| Q3 2014 | $353,000 | +5.7% | 5,500 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $334,000 | +1.5% | 5,500 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $329,000 | -6.0% | 5,500 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $350,000 | -6.4% | 5,500 | 0.0% | 0.01% | -16.7% |
| Q3 2013 | $374,000 | -5.6% | 5,500 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $396,000 | – | 5,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |